ALK-negative anaplastic large cell lymphoma with CNS involvement needs more than just brentuximab vedotin. Ann Hematol 2016 Oct;95(10):1725-6
Date
07/28/2016Pubmed ID
27460479DOI
10.1007/s00277-016-2746-3Scopus ID
2-s2.0-84979688308 (requires institutional sign-in at Scopus site) 15 CitationsAuthor List
Abid MB, Wang S, Loi HY, Poon LMMESH terms used to index this publication - Major topics in bold
Antineoplastic Combined Chemotherapy ProtocolsBlood-Brain Barrier
Brain
Female
Humans
Immunoconjugates
Lymphoma, Large-Cell, Anaplastic
Magnetic Resonance Imaging
Middle Aged
Positron Emission Tomography Computed Tomography
Recurrence
Remission Induction
Salvage Therapy